Racial Disparities in Breast Cancer Diagnosis and Treatment by Hormone Receptor and HER2 Status
- 1 November 2015
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 24 (11) , 1666-1672
Abstract
Background: African American and Hispanic women are more likely to be diagnosed with aggressive forms of breast cancer. Disparities within each subtype of breast cancer have not been well documented. Methods: Using data from 18 SEER cancer registries, we identified 102,064 women aged 20 years or older, diagnosed with invasive breast cancer in 2010–2011, and with known stage, hormone receptor (HR), and HER2 status. Associations between race/ethnicity and cancer stage and receipt of guideline-concordant treatment were evaluated according to HR/HER2 status. Results: Overall, African American and Hispanic women were 30% to 60% more likely to be diagnosed with stage II–IV breast cancer compared with non-Hispanic whites. African American women had 40% to 70% higher risks of stage IV breast cancer across all four subtypes. American Indian/Alaska Native women had a 3.9-fold higher risk of stage IV triple-negative breast cancer. African American and Hispanic whites were 30% to 40% more likely to receive non–guideline-concordant treatment for breast cancer overall and across subtypes. Conclusions: Women in several racial/ethnic groups are more likely to be diagnosed with more advanced stage breast cancer. African American and American Indian/Alaska Native women in particular had the highest risk of being diagnosed with stage IV triple-negative breast cancer. African American and Hispanic women were also consistently at higher risk of not receiving guideline-concordant treatment across subtypes. Impact: These findings provide important characterization of which subtypes of breast cancer racial/ethnic disparities in stage and treatment persist. Cancer Epidemiol Biomarkers Prev; 24(11); 1666–72. ©2015 AACR.Keywords
This publication has 52 references indexed in Scilit:
- Racial disparities in initiation of adjuvant endocrine therapy of early breast cancerBreast Cancer Research and Treatment, 2014
- US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 StatusJNCI: Journal of the National Cancer Institute, 2014
- Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancerBMC Cancer, 2014
- Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women’s Circle of Health StudyCancer Causes & Control, 2013
- Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000–2010BMC Cancer, 2013
- Disparities in survival after female breast cancer diagnosis: a population-based studyCancer Causes & Control, 2013
- Racial Disparities in Treatment and Survival Among Women With Early-Stage Breast CancerJournal of Clinical Oncology, 2005
- Breast and Cervical Cancer Screening: Impact of Health Insurance Status, Ethnicity, and Nativity of LatinasThe Annals of Family Medicine, 2005
- Differences in Breast Cancer Stage, Treatment, and Survival by Race and EthnicityArchives of internal medicine (1960), 2003
- Racial differences in timeliness of follow-up after abnormal screening mammographyCancer, 1996